Literature DB >> 28875883

Central-line-associated bloodstream infections in a resource-limited South African neonatal intensive care unit.

C Geldenhuys1, A Dramowski, A Jenkins, A Bekker.   

Abstract

BACKGROUND: The rate of central-line-associated bloodstream infection (CLABSI) in South African (SA) public sector neonatal intensive care units (NICUs) is unknown. Tygerberg Children's Hospital (TCH), Cape Town, introduced a neonatal CLABSI surveillance and prevention programme in August 2012.
OBJECTIVES: To describe CLABSI events and identify risk factors for development of CLABSI in a resource-limited NICU.
METHODS: A retrospective case-control study was conducted using prospectively collected NICU CLABSI events matched to four randomly selected controls, sampled from the NICU registry between 9 August 2012 and 31 July 2014. Clinical data and laboratory records were reviewed to identify possible risk factors, using stepwise forward logistic regression analysis.
RESULTS: A total of 706 central lines were inserted in 530 neonates during the study period. Nineteen CLABSI events were identified, with a CLABSI rate of 5.9/1 000 line days. CLABSI patients were of lower gestational age (28 v. 34 weeks; p=0.003), lower median birth weight (1 170 g v. 1 975 g; p=0.014), had longer catheter dwell times (>4 days) (odds ratio (OR) 5.1 (95% confidence interval (CI) 1.0 - 25.4); p=0.04) and were more likely to have had surgery during their NICU stay (OR 3.5 (95% CI 1.26 - 10); p=0.01). Significant risk factors for CLABSI were length of stay >30 days (OR 20.7 (95% CI 2.1 - 203.2); p=0.009) and central-line insertion in the operating theatre (OR 8.1 (95% CI 1.2 - 54.7); p=0.03). Gram-negative pathogens predominated (12/22; 54%), with most isolates (10/12; 83%) exhibiting multidrug resistance.
CONCLUSION: The TCH NICU CLABSI rate is similar to that reported from resource-limited settings, but exceeds that of high-income countries. Prolonged NICU stay and central-line insertion in the operating theatre were important risk factors for CLABSI development. Intensified neonatal staff training regarding CLABSI maintenance bundle elements and hand hygiene are key to reducing CLABSI rates.

Entities:  

Year:  2017        PMID: 28875883     DOI: 10.7196/SAMJ.2017.v107i9.12124

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Central line-associated bloodstream infections at the multidisciplinary intensive care unit of Universitas Academic Hospital, Bloemfontein, South Africa.

Authors:  E Glover; A Abrahamson; J Adams; S R Poken; S-L Hainsworth; A Lamprecht; T Delport; T Keulder; T Olivier; S D Maasdorp
Journal:  Afr J Thorac Crit Care Med       Date:  2022-05-05

2.  Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings.

Authors:  Ajay Padmanaban; Ramesh Venkataraman; Senthilkumar Rajagopal; Dedeepiya Devaprasad; Nagarajan Ramakrishnan
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-11-07

Review 3.  Long-term vascular access in differently resourced settings: a review of indications, devices, techniques, and complications.

Authors:  Karen Milford; Dirk von Delft; Nkululeko Majola; Sharon Cox
Journal:  Pediatr Surg Int       Date:  2020-03-21       Impact factor: 1.827

4.  Jejuno-ileal atresia: its characteristics and peculiarities concerning apple peel atresia, focused on its treatment and outcomes as experienced in one of the leading South African academic centres.

Authors:  Hansraj Mangray; Fernando Ghimenton; Colleen Aldous
Journal:  Pediatr Surg Int       Date:  2019-10-29       Impact factor: 1.827

Review 5.  A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective.

Authors:  Emmanuel O Irek; Adewale A Amupitan; Temitope O Obadare; Aaron O Aboderin
Journal:  Afr J Lab Med       Date:  2018-12-06

6.  Bacteriological Profile and Antimicrobial Susceptibility Patterns of Bloodstream Infection at Kigali University Teaching Hospital.

Authors:  Thierry Habyarimana; Didier Murenzi; Emile Musoni; Callixte Yadufashije; François N Niyonzima
Journal:  Infect Drug Resist       Date:  2021-02-23       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.